CNDIF CANADIAN IMPERIAL BANK OF COMMERCE /CAN/
Price Chart
Executive Summary
CIBC filed a 424B5 product supplement for Senior Global Medium-Term Notes linked to equity indices, ETFs, or single stocks, and separately filed a 6-K announcing TSX approval for a new Normal Course Issuer Bid (NCIB) to repurchase up to 30 million common shares (3.3% of outstanding). The 424B5 is a routine shelf takedown document with no specific pricing terms, while the NCIB signals a $2.6B+ capital return program following completion of a prior 20M-share buyback.
Actionable Insight
The 424B5 is a routine shelf supplement with no immediate market impact — no pricing or size disclosed. The NCIB is a modestly positive capital return signal but was pre-announced on May 28, 2026, so the news is stale. Monitor future pricing supplements under the 424B5 for any structured note issuance that could affect CIBC's funding costs. The NCIB provides a floor under the stock during blackout periods via the ASPP, but the 3.3% authorization is within normal range for Canadian banks.
Key Facts
- 424B5 filed under Rule 424(b)(5) for Product Supplement No. WF-2, dated June 4, 2026, covering notes linked to indices, ETFs, or equity securities with principal repayment at maturity subject to CIBC credit risk.
- No specific offering size, pricing, or coupon terms are disclosed in the 424B5 — those will appear in separate pricing supplements.
- 6-K filed June 4, 2026: TSX accepted CIBC's new NCIB to repurchase up to 30 million common shares (~3.3% of 912.8M shares outstanding as of May 31, 2026).
- Previous NCIB of 20 million shares was completed on May 25, 2026 at an average price of C$129.68/share for a total of C$2.6 billion.
- Combined repurchases under both NCIBs represent ~5.5% of CIBC's public float of 912.6M shares.
- New NCIB may commence on or after June 8, 2026 and expires June 7, 2027; CIBC Capital Markets retained as designated broker under an automatic share purchase plan.
- Average daily trading volume for the six months ended May 31, 2026 was 2,692,339 shares; maximum daily purchase under TSX rules is 673,084 shares.
Financial Impact
C$2.6 billion deployed in prior NCIB at C$129.68/share; new NCIB authorizes up to 30M shares at market prices — no dollar cap disclosed.
Risk Factors
- No specific offering terms in the 424B5 — future pricing supplements could contain dilutive or complex structured note terms.
- NCIB execution depends on market conditions; actual repurchases may fall short of the 30M share authorization.
- Forward-looking statements in the NCIB release are subject to economic and regulatory risks.
Market Snapshot
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (CNDIF) — Batch item 1 | 0001918704-26-015700 |
| Document: 0001918704-26-015700-index-headers.html | 0001279569-26-000508 |
| Document: 0001918704-26-015700-index.html | 0001918704-26-015700 |
| Document: 0001918704-26-015700.txt | 0001918704-26-015700 |
| 6-K Filing (CNDIF) — Batch item 5 | 0001279569-26-000508 |
| Exhibit: ex991.htm | 0001918704-26-015700 |
| Document: 0001279569-26-000508-index-headers.html | 0001918704-26-015700 |
| Document: 0001279569-26-000508-index.html | 0001918704-26-015700 |
| Document: 0001279569-26-000508.txt | 0001918704-26-015700 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
today
|
EFFECT
| — | awaiting T+5 | — | — |
|
Jun 4, 2026
1d ago
|
424B5
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
Jun 4, 2026
1d ago
|
424B5
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
Jun 4, 2026
1d ago
|
424B5 / 6-K
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
Jun 4, 2026
1d ago
|
424B5
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
Jun 4, 2026
1d ago
|
424B5
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
Jun 4, 2026
1d ago
|
424B5
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
Jun 4, 2026
1d ago
|
424B5
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
Jun 4, 2026
1d ago
|
424B5
| $0.4600 awaiting T+5 | awaiting T+5 | — | $0.4500 (−2.17%) |
|
May 28, 2026
8d ago
|
6-K
| $0.4880 $0.5600 | ▲ +14.75% | ▲ +14.80% | $0.4500 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access